These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 1979068)

  • 1. Participation of CD11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes.
    Timonen T; Gahmberg CG; Patarroyo M
    Int J Cancer; 1990 Dec; 46(6):1035-40. PubMed ID: 1979068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of CD11a-c/CD18 and RGD-recognizing adhesion molecules in the binding of LGL to fibroblasts. Evidence for the role of CD11a in the fibroblast-mediated inactivation of NK cells.
    Heiskala MK; Patarroyo M; Timonen TT
    Scand J Immunol; 1990 Aug; 32(2):137-47. PubMed ID: 1697097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
    Robertson MJ; Caligiuri MA; Manley TJ; Levine H; Ritz J
    J Immunol; 1990 Nov; 145(10):3194-201. PubMed ID: 1700001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
    Zarcone D; Viale O; Cerruti G; Tenca C; Malorni W; Arancia G; Iosi F; Galandrini R; Velardi A; Moretta A
    Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells.
    Oblakowski P; Bello-Fernandez C; Reittie JE; Heslop HE; Galatowicz G; Veys P; Wilkes S; Prentice HG; Hazlehurst G; Hoffbrand AV
    Blood; 1991 May; 77(9):1996-2001. PubMed ID: 1708296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric scFv/gamma receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory molecules.
    Weijtens ME; Willemsen RA; van Krimpen BA; Bolhuis RL
    Int J Cancer; 1998 Jul; 77(2):181-7. PubMed ID: 9650549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cultured human thymocytes lacking CD2 and CD11a/CD18 antigens are functional and adhere to endothelial cells via CD56 or CDw49d molecules.
    Poggi A; Zocchi MR
    Cell Immunol; 1992 Apr; 140(2):319-30. PubMed ID: 1371947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of human natural killer cell cytotoxicity by Salmonella bacteria is an interferon- and interleukin-2-independent process that utilizes CD2 and CD18 structures in the effector phase.
    Tarkkanen J; Saksela E
    Infect Immun; 1991 Aug; 59(8):2767-73. PubMed ID: 1713200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD11a-c/CD18 and GP84 (LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing.
    Timonen T; Patarroyo M; Gahmberg CG
    J Immunol; 1988 Aug; 141(3):1041-6. PubMed ID: 2899596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion characteristics of human interleukin 2-activated natural killer cells.
    Melder RJ; Walker E; Herberman RB; Whiteside TL
    Cell Immunol; 1991 Jan; 132(1):177-92. PubMed ID: 1905985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte-cell adhesion: a molecular process fundamental in leukocyte physiology.
    Patarroyo M; Prieto J; Rincon J; Timonen T; Lundberg C; Lindbom L; Asjö B; Gahmberg CG
    Immunol Rev; 1990 Apr; 114():67-108. PubMed ID: 1973408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
    Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
    Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion of CD16+ K cells to antibody-coated targets is mediated by CD2 and CD18 receptors.
    Voltarelli JC; Gjerset G; Anasetti C
    Immunology; 1993 Jul; 79(3):509-11. PubMed ID: 8104886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
    Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules.
    Chong AS; Boussy IA; Graf LH; Scuderi P
    Cell Immunol; 1992 Oct; 144(1):69-79. PubMed ID: 1356634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD18/CD54(+CD102), CD2/CD58 pathway-independent killing of lymphokine-activated killer (LAK) cells against glioblastoma cell lines T98G and U373MG.
    Komatsu F; Kajiwara M
    Oncol Res; 2000; 12(1):17-24. PubMed ID: 11061342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesion molecules on MHC-nonrestricted lymphocytes: high density expression and role in oncolysis.
    Savary CA; Lotzová E
    Lymphokine Cytokine Res; 1992 Jun; 11(3):149-56. PubMed ID: 1391234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD18 in lymphokine activated killer (LAK) cell-mediated lysis of human monocytes: comparison with other LAK targets.
    Blanchard DK; Hall RE; Djeu JY
    Int J Cancer; 1990 Feb; 45(2):312-9. PubMed ID: 1968054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion molecules on freshly recovered T leukemias promote tumor-directed lympholysis.
    Schirren CA; Völpel H; Meuer SC
    Blood; 1992 Jan; 79(1):138-43. PubMed ID: 1370201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against LFA-1 or its ligand ICAM-1 accelerate CD2 (T11.1 + T11.2)-mediated T cell proliferation.
    Cerdan C; Lipcey C; Lopez M; Nunes J; Pierres A; Mawas C; Olive D
    Cell Immunol; 1989 Oct; 123(2):344-53. PubMed ID: 2571421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.